Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
Chart tumour evolution using cutting-edge long-read and single-cell multiomics Who we are The Integrative Cancer Genomics lab (Jonas Demeulemeester) is embedded within the VIB – KU Leuven Center
-
learning, with access to VIB’s personal and professional development programs. How to apply? Motivated candidates can apply via the online VIB application form (https://jobs.vib.be/apply/132752
-
development. Competitive salary and benefits. Full‑time, indefinite contract with flexible working arrangements. How to apply Apply via the online application tool (https://jobs.vib.be/apply/132489 ). Include
-
beyond. You help define and improve processes, introduce practical ways of working, and support the gradual development of a project approach that fits VIB’s culture. You will report to the ICT Director of
-
Saelens team. Research Project In this research project you will develop probabilistic deep-learning models that automatically extract biological and statistical knowledge from in vivo perturbational omics
-
Leuven, Belgium and is part of the VIB-KU Leuven Center for Neuroscience . The Verstreken lab is developing advanced multielectrode array systems to mimic human brain circuits relevant to neurodegenerative
-
conduct innovative and internationally recognized research in the field of artificial intelligence and the development of innovative machine learning methods to address fundamental questions in (bio)medical
-
leading research institute focused on understanding cancer biology and developing innovative therapies. Our Bioinformatics & AI Expertise Unit provides advanced computational support to multiple research
-
homeostasis to disease. About the role We are seeking a motivated software developer who wants to join the Saeys lab within the VIB-UGent Center for Inflammation Research to help develop, maintain and extend
-
for Neuroscience . The Verstreken lab is developing advanced multielectrode array systems to mimic human brain circuits relevant to neurodegenerative disease. They are also conducting advanced CRISPR screens